Trials / Completed
CompletedNCT04196335
I Can sEe Left Atrial Appendage (ICELAA) Clinical Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Boston Scientific Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The primary objective of this study is to assess the efficacy and safety of using intra-procedural intracardiac echocardiography (ICE) for WATCHMAN FLX Device implants in subjects with non-valvular atrial fibrillation to reduce the risk of stroke.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | intra-procedural intracardiac echocardiography | use of intra-procedural intracardiac echocardiography during Watchman FLX devices |
Timeline
- Start date
- 2020-07-29
- Primary completion
- 2021-09-24
- Completion
- 2021-09-24
- First posted
- 2019-12-12
- Last updated
- 2025-06-18
Locations
7 sites across 4 countries: Denmark, Italy, Spain, United Kingdom
Source: ClinicalTrials.gov record NCT04196335. Inclusion in this directory is not an endorsement.